{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:07:59Z","timestamp":1789834079967,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20210006"],"award-info":[{"award-number":["20210006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05076-6","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:05:35Z","timestamp":1772611535000},"page":"3119-3129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SCGB1A1 suppresses prostate cancer proliferation and metastasis by modulating the MAPK signaling pathway"],"prefix":"10.1007","volume":"58","author":[{"given":"Wanli","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"1","key":"5076_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL et al (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5076_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5076_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3322\/caac.70011","volume":"75","author":"NS Wagle","year":"2025","unstructured":"Wagle NS et al (2025) Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin 75(4):308\u2013340. https:\/\/doi.org\/10.3322\/caac.70011","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"5076_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","volume":"391","author":"J Hugosson","year":"2024","unstructured":"Hugosson J et al (2024) Results after four years of screening for prostate cancer with PSA and MRI. N Engl J Med 391(12):1083\u20131095. https:\/\/doi.org\/10.1056\/NEJMoa2406050","journal-title":"N Engl J Med"},{"issue":"14","key":"5076_CR5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMc2406108","volume":"391","author":"L Holmberg","year":"2024","unstructured":"Holmberg L et al (2024) Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 391(14):1362\u20131364. https:\/\/doi.org\/10.1056\/NEJMc2406108","journal-title":"N Engl J Med"},{"issue":"18","key":"5076_CR6","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.7150\/thno.100555","volume":"14","author":"SB Hansen","year":"2024","unstructured":"Hansen SB et al (2024) Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management. Theranostics 14(18):6913\u20136934. https:\/\/doi.org\/10.7150\/thno.100555","journal-title":"Theranostics"},{"issue":"3","key":"5076_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MOU.0b013e328344f3e3","volume":"21","author":"FC da Silva","year":"2011","unstructured":"da Silva FC (2011) Intermittent hormonal therapy for prostate cancer. Curr Opin Urol 21(3):248\u2013251. https:\/\/doi.org\/10.1097\/MOU.0b013e328344f3e3","journal-title":"Curr Opin Urol"},{"issue":"16","key":"5076_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB (2025) Prostate cancer: A review. JAMA 333(16):1433\u20131446. https:\/\/doi.org\/10.1001\/jama.2025.0228","journal-title":"JAMA"},{"issue":"10","key":"5076_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.2024.13806","volume":"332","author":"MR Goldstein","year":"2024","unstructured":"Goldstein MR, Mascitelli L (2024) PSA screening and prostate cancer mortality. JAMA 332(10):843. https:\/\/doi.org\/10.1001\/jama.2024.13806","journal-title":"JAMA"},{"key":"5076_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1749-6632.2000.tb05549.x","volume":"923","author":"J Klug","year":"2000","unstructured":"Klug J et al (2000) Uteroglobin\/Clara cell 10-kDa family of proteins: Nomenclature committee report. Ann N Y Acad Sci 923:348\u2013354. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05549.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"5076_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.stem.2009.04.002","volume":"4","author":"EL Rawlins","year":"2009","unstructured":"Rawlins EL et al (2009) The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4(6):525\u2013534. https:\/\/doi.org\/10.1016\/j.stem.2009.04.002","journal-title":"Cell Stem Cell"},{"key":"5076_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-med-042921-123443","volume":"74","author":"T Martinu","year":"2023","unstructured":"Martinu T et al (2023) Club Cell Secretory Protein in lung disease: emerging concepts and potential therapeutics. Annu Rev Med 74:427\u2013441. https:\/\/doi.org\/10.1146\/annurev-med-042921-123443","journal-title":"Annu Rev Med"},{"issue":"10","key":"5076_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1164\/rccm.202303-0500OC","volume":"210","author":"N Olvera","year":"2024","unstructured":"Olvera N et al (2024) Lung tissue multilayer network analysis uncovers the molecular heterogeneity of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 210(10):1219\u20131229. https:\/\/doi.org\/10.1164\/rccm.202303-0500OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"5076_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42(2):293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5076_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13059-020-1950-6","volume":"21","author":"S Yang","year":"2020","unstructured":"Yang S et al (2020) Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol 21(1):57. https:\/\/doi.org\/10.1186\/s13059-020-1950-6","journal-title":"Genome Biol"},{"key":"5076_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.2","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain PL et al (2021) Doublet identification in single-cell sequencing data using scDblFinder. F1000Res 10:979. https:\/\/doi.org\/10.12688\/f1000research.73600.2","journal-title":"F1000Res"},{"issue":"8","key":"5076_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537\u2013549. https:\/\/doi.org\/10.1038\/nrc2694","journal-title":"Nat Rev Cancer"},{"key":"5076_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"R Ullah","year":"2022","unstructured":"Ullah R et al (2022) RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol 85:123\u2013154. https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.010","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5076_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8(1):455. https:\/\/doi.org\/10.1038\/s41392-023-01705-z","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"5076_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2159-8290.Cd-24-0139","volume":"14","author":"MB Ryan","year":"2024","unstructured":"Ryan MB et al (2024) The Pan-RAF-MEK nondegrading molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS-MAPK pathway with activity across diverse RAS- and RAF-driven cancers. Cancer Discov 14(7):1190\u20131205. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0139","journal-title":"Cancer Discov"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05076-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05076-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:18:45Z","timestamp":1784193525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05076-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5076"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05076-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Cangzhou Central Hospital. The research is consistent with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}